Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(2):128-133; doi:10.1093/jnci/93.2.128
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ponten, F.
Right arrow Articles by Bergh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponten, F.
Right arrow Articles by Bergh, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 2, 128-133, January 17, 2001
© 2001 Oxford University Press


REPORT

Induction of p53 Expression in Skin by Radiotherapy and UV Radiation: a Randomized Study

Fredrik Ponten, Henrik Lindman, Asa Bostrom, Berit Berne, Jonas Bergh

Affiliations of authors: F. Ponten (Department of Genetics and Pathology), H. Lindman (Department of Oncology), A. Bostrom, B. Berne (Department of Dermatology), University Hospital, Uppsala, Sweden; J. Bergh, Department of Oncology, Karolinska Hospital, Stockholm, Sweden.

Correspondence to: Fredrik Ponten, M.D., Ph.D., Department of Genetics and Pathology, University Hospital, S-751 85 Uppsala, Sweden (e-mail: Fredrik.Ponten{at}genpat.uu.se).

Background: p53 protein plays an important role in the response to DNA damage, and radiotherapy can cause radiation dermatitis. p53 and p21 levels increase in vitro when DNA is damaged by UVA, UVB, or {gamma}-radiation. To determine whether this response occurs in human skin and predicts the level of radiation dermatitis, we investigated levels of p53 and p21 in skin exposed to different types of radiation as part of a randomized study of women with breast cancer to evaluate topical steroid or emollient cream treatments for radiation dermatitis of their irradiated breast. Methods: After surgery but before receiving tangential 5-mV photo-beam radiotherapy (2 Gy and 54 Gy) to the affected breast parenchyma, multiple areas on the backs of 50 women were irradiated with UVA and other areas were irradiated with UVB. Skin biopsy samples were taken from areas of normal unirradiated skin and all irradiated areas, and p53 and p21 were detected immunohistochemically. All statistical tests are two-sided. Results: In skin irradiated with UVA or UVB, medians of 4.4% (range = 0%–40.5%) or 45.5% (range = 5.3%–74.6%) p53-positive keratinocytes, respectively, were observed. Radiotherapy produced medians of 31.0% (range = 0%–79.3%) p53-immunoreactive cells after 2 Gy of radiation and 83.2% (range = 37.6%–95.2%) after 54 Gy of radiation. Despite large interindividual differences in p53 response, comparable increases in epidermal p53 response were independent of the type of radiation. A correlation between p53 and p21 was also evident (rs = .78). In breast skin, there was no association between the p53 response and the degree of erythema (a measure of radiation dermatitis) and no statistically significant difference between treatment arms and p21/p53 responses. Conclusions: Individual responses to radiation-induced DNA damage varied widely and may be independent of the type of radiation. The epidermal p53 response does not predict the degree of radiation dermatitis.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Brellier, C. Marionnet, O. Chevallier-Lagente, R. Toftgard, A. Mauviel, A. Sarasin, and T. Magnaldo
Ultraviolet Irradiation Represses PATCHED Gene Transcription in Human Epidermal Keratinocytes through an Activator Protein-1-Dependent Process
Cancer Res., April 15, 2004; 64(8): 2699 - 2704.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Harrod, J. Nacsa, C. Van Lint, J. Hansen, T. Karpova, J. McNally, and G. Franchini
Human Immunodeficiency Virus Type-1 Tat/Co-activator Acetyltransferase Interactions Inhibit p53Lys-320 Acetylation and p53-responsive Transcription
J. Biol. Chem., March 28, 2003; 278(14): 12310 - 12318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Ling, A. Persson, B. Berne, M. Uhlen, J. Lundeberg, and F. Ponten
Persistent p53 Mutations in Single Cells from Normal Human Skin
Am. J. Pathol., October 1, 2001; 159(4): 1247 - 1253.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
M. Ljungman
Individual Variation in p53 Responsiveness
J Natl Cancer Inst, January 17, 2001; 93(2): 82 - 83.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.